February 18, 2025 C-Path’s CPA-1 Consortium Welcomes Newest Members Kamada, Sanofi Critical Path for Alpha-1 (CPA-1) consortium today announced the addition of biopharmaceutical companies, Kamada and Sanofi.
January 23, 2025 C-Path Announces Jennifer Kendra as New Vice President of Strategic Partnerships New Leadership to Drive Expansion of Collaborative Initiatives and Fundraising Strategies at C-Path.
January 14, 2025 C-Path’s TRxA Announces 2025 Request for Proposals from Academic Investigators C-Path and TRxA today officially launched its 2025 global Request for Proposals for Bridging Research...
November 19, 2024 C-Path’s TRxA Announces $1 Million Award for Drug Development Project in Type 1 Diabetes C-Path today announced that its Translational Therapeutics Accelerator (TRxA) program, in partnership...
November 13, 2024 C-Path Announces Global Evidence in Medicine for Parkinson’s Disease (GEM‑PD) Initiative C-Path expands its worldwide leadership in accelerating drug development in neurology; seeks additional collaborators to broaden..
November 7, 2024 C-Path Announces Key Leadership Appointments in Neurodegenerative Disease Research Dr. Diane Stephenson Promoted to Vice President of Neurology; Dr. Nadine Tatton Welcomed as New Executive Director of CPAD.
October 16, 2024 Sanford Health Rare Disease Data Registry and C-Path’s RDCA-DAP Enter into a Master Data Contribution Agreement to Aggregate Rare Disease Data Critical Path Institute (C-Path) is pleased to announce the expansion of our partnership with the Coordination...
October 1, 2024 The AMR Accelerator Calls to Action: European Capacity for Antibiotic R&D Requires Long-term Funding Note: You are reading this information because Critical Path Institute is a partner of both ERA4TB and Unite4TB.
September 30, 2024 C-Path to Lead Comprehensive Task Force Focused on Accelerating Drug Development for Limb-Girdle Muscular Dystrophies C-Path announced the formation of a new task for under its RDCA-DAP, dedicated to...
September 19, 2024 C-Path’s PKD Outcomes Consortium Receives BAA Award for Project to Advance Drug Development Tools for Autosomal Dominant Tubulointerstitial Kidney Disease C-Path is thrilled to announce its PKDOC has been awarded...
